跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,668 条关于
“primary humoral immunodeficiency”
全部
32,668
临床试验
21,575
药物
90
机构
37
资讯
10,966
11个月前
Kedrion Biopharma Secures FDA Approval for QIVIGY, First Proprietary IVIG Therapy for Primary Immunodeficiency
4个月前
FDA Expands ASCENIV Label to Include Pediatric Patients as Young as Two Years for Primary Immunodeficiency Treatment
2个月前
Grifols Doses First Patients in Two Phase 3 Trials to Expand Labels for Gamunex-C and Xembify
去年
FDA Approves ADMA Biologics' Innovative Yield Enhancement Process for Immune Globulin Production
7个月前
Takeda Launches GAMMAGARD LIQUID ERC, First Ready-to-Use Low-IgA Immunoglobulin Therapy in U.S.
4年前
Subcutaneous Immunoglobulin 20% Effective for Primary Immunodeficiency
去年
FDA Approves Takeda's GAMMAGARD LIQUID ERC, First Ready-to-Use Low IgA Immunoglobulin Therapy for Primary Immunodeficiency
11个月前
FDA Grants Priority Review for Leniolisib in Children with Rare Immunodeficiency APDS
3个月前
Humoral Immunity Emerges as a Spatially Organized, State-Dependent Axis of Antitumor Defense and Therapeutic Targeting
2年前
FDA Approves Expanded Label for Grifols' Xembify, Allowing Treatment-Naïve PI Patients Subcutaneous Immunoglobulin Therapy
第 1 页，共 1097 页
上一页
下一页
